Purmycin-125 Suspension, Purmycin-250 Suspension 125 mg, 250 mg Suspension
PDF Leaflet Revision Date: 03 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for various infections including respiratory, urinary, gastrointestinal, and skin infections.
Dosage (summary)
Adults: 250-500 mg every 6 hours before meals; may double in severe infections.
Special Populations
- Elderly
- Patients with liver impairment
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; caution advised.
Key Drug Interactions
- Increased effects of carbamazepine, corticosteroids, digoxin
- Avoid with simvastatin, terfenadine, pimozide
Contraindications
- Hypersensitivity to erythromycin
- Liver impairment
- QT prolongation history
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Rash
- Torsade de pointes
Counselling Points
- Complete the prescribed course
- Monitor for signs of allergic reactions
- Inform about potential gastrointestinal side effects
Serious warnings
- Risk of pseudomembranous colitis
- Potential for serious allergic reactions
Important Disclaimer
The Purmycin-125 Suspension, Purmycin-250 Suspension 125 mg, 250 mg Suspension professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
